Improvement of Sepsis Prognosis by Ulinastatin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Conclusions: Ulinastatin improved all-cause mortality and other related outcomes in patients with sepsis or septic shock. The results of this meta-analysis suggest that ulinastatin may be an effective treatment for sepsis and septic shock.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: China Health | Databases & Libraries | Drugs & Pharmacology | Physiology | Septic Shock | Study